ALK GENE REARRANGEMENT
Clinical trials for ALK GENE REARRANGEMENT explained in plain language.
Never miss a new study
Get alerted when new ALK GENE REARRANGEMENT trials appear
Sign up with your email to follow new studies for ALK GENE REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on advanced lung cancer shows early promise
Disease control OngoingThis early trial tests whether adding surgery or radiation to the targeted drug brigatinib can better control advanced ALK-positive non-small cell lung cancer. About 35 people whose cancer has spread or returned will receive both treatments. The main goal is to check safety and s…
Matched conditions: ALK GENE REARRANGEMENT
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Immunotherapy duo plus radiation shows promise in lung cancer trial
Disease control OngoingThis early-phase trial is testing whether combining two immunotherapy drugs (ipilimumab and nivolumab) with radiation therapy is safe and effective for people with stage II or III non-small cell lung cancer that cannot be removed by surgery. The goal is to see if this approach ca…
Matched conditions: ALK GENE REARRANGEMENT
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Targeted pill after lung cancer surgery may keep the disease from coming back
Disease control OngoingThis study looks at whether taking crizotinib after surgery can help people with early-stage ALK-positive lung cancer live longer without the cancer returning. About 166 people who had their lung cancer removed will either take crizotinib or just be watched. The goal is to see if…
Matched conditions: ALK GENE REARRANGEMENT
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:53 UTC